Atlantic Union Bankshares Corp Novartis Ag Transaction History

Atlantic Union Bankshares Corp

  • $1.62 Billion
  • Q3 2024

A detailed history of Atlantic Union Bankshares Corp transactions in Novartis Ag stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 17,711 shares of NVS stock, worth $1.74 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
17,711
Previous 17,881 0.95%
Holding current value
$1.74 Million
Previous $1.9 Million 7.04%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $18,042 - $20,551
-170 Reduced 0.95%
17,711 $2.04 Million
Q2 2024

Jul 24, 2024
SELL
$92.57 - $107.37 $12,589 - $14,602
-136 Reduced 0.75%
17,881 $1.9 Million
Q1 2024

Apr 16, 2024
SELL
$95.27 - $108.47 $128,519 - $146,326
-1,349 Reduced 6.97%
18,017 $1.74 Million
Q4 2023

Jan 19, 2024
SELL
$92.27 - $101.54 $196,627 - $216,381
-2,131 Reduced 9.91%
19,366 $1.96 Million
Q3 2023

Oct 20, 2023
SELL
$94.73 - $105.13 $115,002 - $127,627
-1,214 Reduced 5.35%
21,497 $2.19 Million
Q2 2023

Jul 11, 2023
SELL
$92.52 - $104.91 $74,386 - $84,347
-804 Reduced 3.42%
22,711 $2.29 Million
Q1 2023

May 08, 2023
SELL
$80.03 - $92.81 $105,399 - $122,230
-1,317 Reduced 5.3%
23,515 $2.16 Million
Q4 2022

Feb 09, 2023
SELL
$75.55 - $92.52 $50,542 - $61,895
-669 Reduced 2.62%
24,832 $2.25 Million
Q3 2022

Oct 25, 2022
SELL
$74.61 - $87.26 $225,844 - $264,136
-3,027 Reduced 10.61%
25,501 $1.94 Million
Q2 2022

Jul 21, 2022
SELL
$80.52 - $93.75 $111,359 - $129,656
-1,383 Reduced 4.62%
28,528 $2.41 Million
Q1 2022

Apr 26, 2022
SELL
$80.11 - $90.62 $350,881 - $396,915
-4,380 Reduced 12.77%
29,911 $2.63 Million
Q4 2021

Jan 19, 2022
SELL
$79.7 - $88.13 $1.24 Million - $1.37 Million
-15,579 Reduced 31.24%
34,291 $3 Million
Q3 2021

Oct 26, 2021
SELL
$81.78 - $95.14 $842,579 - $980,227
-10,303 Reduced 17.12%
49,870 $4.08 Million
Q2 2021

Jul 26, 2021
SELL
$85.24 - $94.15 $846,177 - $934,627
-9,927 Reduced 14.16%
60,173 $5.49 Million
Q1 2021

May 04, 2021
BUY
$83.5 - $98.47 $64,545 - $76,117
773 Added 1.12%
70,100 $5.99 Million
Q4 2020

Feb 01, 2021
BUY
$78.07 - $94.43 $51,682 - $62,512
662 Added 0.96%
69,327 $6.55 Million
Q3 2020

Oct 16, 2020
BUY
$82.14 - $91.0 $2,217 - $2,457
27 Added 0.04%
68,665 $5.97 Million
Q2 2020

Jul 15, 2020
BUY
$80.93 - $91.1 $143,974 - $162,066
1,779 Added 2.66%
68,638 $6 Million
Q1 2020

Apr 10, 2020
SELL
$70.67 - $99.01 $166,074 - $232,673
-2,350 Reduced 3.4%
66,859 $5.51 Million
Q4 2019

Jan 14, 2020
BUY
$84.35 - $95.37 $26,570 - $30,041
315 Added 0.46%
69,209 $6.55 Million
Q3 2019

Oct 17, 2019
SELL
$85.54 - $94.26 $11,547 - $12,725
-135 Reduced 0.2%
68,894 $5.99 Million
Q2 2019

Jul 23, 2019
BUY
$75.4 - $92.8 $2.56 Million - $3.15 Million
33,987 Added 96.99%
69,029 $6.3 Million
Q1 2019

Apr 10, 2019
SELL
$75.32 - $86.15 $249,007 - $284,811
-3,306 Reduced 8.62%
35,042 $3.37 Million
Q4 2018

Jan 14, 2019
SELL
$73.66 - $82.02 $33,073 - $36,826
-449 Reduced 1.16%
38,348 $3.29 Million
Q3 2018

Oct 11, 2018
SELL
$66.94 - $77.43 $3,547 - $4,103
-53 Reduced 0.14%
38,797 $3.34 Million
Q2 2018

Jul 12, 2018
SELL
$64.91 - $73.36 $27,132 - $30,664
-418 Reduced 1.06%
38,850 $2.94 Million
Q1 2018

Apr 11, 2018
BUY
$70.39 - $84.15 $116,777 - $139,604
1,659 Added 4.41%
39,268 $3.18 Million
Q4 2017

Jan 10, 2018
BUY
$72.33 - $77.64 $25,098 - $26,941
347 Added 0.93%
37,609 $3.16 Million
Q3 2017

Oct 13, 2017
BUY
$74.14 - $77.27 $2.76 Million - $2.88 Million
37,262
37,262 $3.2 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Atlantic Union Bankshares Corp Portfolio

Follow Atlantic Union Bankshares Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email